Education Library

Bobby Yeh, MD, discusses how real-world evidence factors into treatment decisions made every day in clinical practice.

Navin Kapur, MD, discusses the latest science underlying reperfusion and unloading and how it led to the STEMI-DTU pilot and pivotal trials.

Kate Kearney, MD, discusses studies and strategies for revascularization in heart failure with reduced ejection fraction.

Navin Kapur, MD, discusses clinical evidence to support ‘on-pump’ complex PCI for patients with heart failure.

Gregg Stone, MD, reviews available data—from PROTECT II through PROTECT IV—for use of mechanical circulatory support during high-risk PCI.

Hady Lichaa, MD, discusses an innovative single-access dry-closure technique with iliac artery angioplasty through the ipsilateral sheath.

Rajan Patel, MD, discusses clinical data supporting Impella® use in Protected PCI and cardiogenic shock at the CRT 2021 virtual annual symposium. 

The PROTECT IV RCT will leverage advancements in technology and best practices learned since the completion of the PROTECT II RCT and the FDA pre-market approval for Impella 2.5® for high-risk PCI. 

This live case highlights high-risk PCI involving a calcified graft lesion treated with orbital atherectomy and stenting with Impella heart pump hemodynamic support.

Kiyotake Ishikawa, MD, discusses his paper on the impact of Impella on dissected coronary artery hemodynamics in a porcine model.